Evidence map›Paper›PMID 32408336›Full record

ArticleNature2020

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.

Denisa Bojkova, Kevin Klann, Benjamin Koch, Marek Widera, David Krause, Sandra Ciesek, Jindrich Cinatl, Christian Münch

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 652 papers.

0numbers the graph read from it
0cells of the map it votes in
652citing papers in PubMed
24.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

652 citing papers in PubMed, 1,099 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A bireporter recombinant SARS-CoV-2 Omicron BA.5 forbioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. The ribosomal landscape in influenza A virus infection: from molecular mechanisms to clinical relevance.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  18. Article
  19. Review
  20. Article

592 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Denisa Bojkova *Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Kevin Klann *Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0003-2276-8128
Benjamin Koch *Medical Clinic III, Nephrology, University Hospital Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-3253-8396
Marek WideraInstitute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0001-5417-9307
David KrauseInstitute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.
Sandra CiesekInstitute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-1802-7565
Jindrich CinatlInstitute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany. cinatl@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0002-6744-2087
Christian MünchInstitute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany. ch.muench@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0003-3832-090X
Goethe University Frankfurt · DE

Funding

European Research Council 803565
6 · The paper itself

Abstract

A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes coronavirus disease 2019 (COVID-19) and has been rapidly spreading around the globe

Indexed as

Molecular Targeted TherapyProteomicsBetacoronavirusCaco-2 CellsCarbonCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentDrug Evaluation, PreclinicalHost-Pathogen InteractionsHumansIn Vitro TechniquesKineticsPandemicsPneumonia, ViralProtein BiosynthesisCarbonProteome

Identifiers

PMID32408336
PMCPMC7616921
OpenAlexW3026002191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.